Log in to save to my catalogue

BRIVA‐ONE study: 12‐month outcomes of brivaracetam monotherapy in clinical practice

BRIVA‐ONE study: 12‐month outcomes of brivaracetam monotherapy in clinical practice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_32c4e0c66920408ca15b1719300abbb7

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Objective
This study investigated the effectiveness and tolerability of brivaracetam (BRV) monotherapy in a large series of patients with epilepsy.
Method
This was a multicenter, retrospective, observational, non‐interventional study in 24 hospitals across Spain. Patients aged ≥18 years who started on BRV monotherapy, either as first‐line...

Alternative Titles

Full title

BRIVA‐ONE study: 12‐month outcomes of brivaracetam monotherapy in clinical practice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_32c4e0c66920408ca15b1719300abbb7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_32c4e0c66920408ca15b1719300abbb7

Other Identifiers

ISSN

2470-9239

E-ISSN

2470-9239

DOI

10.1002/epi4.13078

How to access this item